EPH237 The Health Impact of Pembrolizumab for the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC) That Expresses High Levels of PD-L1 in Türkiye
Abstract
Authors
Burcu Akyol Ersoy Yasemin Ceylan Ugur Akpamuk Gozde Ozcan Yasemin Esen Mert Batum Berfin Torun Bernadette Poellinger Carole Mamane Ralph Insinga Sylvi Nguyen Simten Malhan Irfan Cicin